商品名(trade name) | |
藥理作用(Pharmacological Effects) | [GLP-1 analogues [the following is GIT hormone function, but GLP-1 and GLP-1 is often broken down by DPP-IV enzyme[[increase insulin releasing [[reduce glucagon  資料來源：efunet [other GIT hormone pathway drug 參見：Dipeptidyl peptidase-IV inhibitors/Sitagliptin |
用量與用法(Dosage and Usage) | usage ]injection |
適應症(Indications) | {type II diabetes |
副作用(Side effect) | |
禁忌/交互作用(Contraindications / interaction) |
Monday, October 21, 2013
Exenatide
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment